Cargando…
Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model
BACKGROUND: Charcot-Marie-Tooth (CMT) disease is the most common neuromuscular disorder in humans affecting 40 out of 100,000 individuals. In 2008, we described the clinical, electrophysiological and pathological findings of a demyelinating motor and sensory neuropathy in Miniature Schnauzer dogs, w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875392/ https://www.ncbi.nlm.nih.gov/pubmed/31772832 http://dx.doi.org/10.7717/peerj.7983 |
_version_ | 1783473020641214464 |
---|---|
author | Granger, Nicolas Luján Feliu-Pascual, Alejandro Spicer, Charlotte Ricketts, Sally Hitti, Rebekkah Forman, Oliver Hersheson, Joshua Houlden, Henry |
author_facet | Granger, Nicolas Luján Feliu-Pascual, Alejandro Spicer, Charlotte Ricketts, Sally Hitti, Rebekkah Forman, Oliver Hersheson, Joshua Houlden, Henry |
author_sort | Granger, Nicolas |
collection | PubMed |
description | BACKGROUND: Charcot-Marie-Tooth (CMT) disease is the most common neuromuscular disorder in humans affecting 40 out of 100,000 individuals. In 2008, we described the clinical, electrophysiological and pathological findings of a demyelinating motor and sensory neuropathy in Miniature Schnauzer dogs, with a suspected autosomal recessive mode of inheritance based on pedigree analysis. The discovery of additional cases has followed this work and led to a genome-wide association mapping approach to search for the underlying genetic cause of the disease. METHODS: For genome wide association screening, genomic DNA samples from affected and unaffected dogs were genotyped using the Illumina CanineHD SNP genotyping array. SBF2 and its variant were sequenced using primers and PCRs. RNA was extracted from muscle of an unaffected and an affected dog and RT-PCR performed. Immunohistochemistry for myelin basic protein was performed on peripheral nerve section specimens. RESULTS: The genome-wide association study gave an indicative signal on canine chromosome 21. Although the signal was not of genome-wide significance due to the small number of cases, the SBF2 (also known as MTMR13) gene within the region of shared case homozygosity was a strong positional candidate, as 22 genetic variants in the gene have been associated with demyelinating forms of Charcot-Marie-Tooth disease in humans. Sequencing of SBF2 in cases revealed a splice donor site genetic variant, resulting in cryptic splicing and predicted early termination of the protein based on RNA sequencing results. CONCLUSIONS: This study reports the first genetic variant in Miniature Schnauzer dogs responsible for the occurrence of a demyelinating peripheral neuropathy with abnormally folded myelin. This discovery establishes a genotype/phenotype correlation in affected Miniature Schnauzers that can be used for the diagnosis of these dogs. It further supports the dog as a natural model of a human disease; in this instance, Charcot-Marie-Tooth disease. It opens avenues to search the biological mechanisms responsible for the disease and to test new therapies in a non-rodent large animal model. In particular, recent gene editing methods that led to the restoration of dystrophin expression in a canine model of muscular dystrophy could be applied to other canine models such as this before translation to humans. |
format | Online Article Text |
id | pubmed-6875392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68753922019-11-26 Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model Granger, Nicolas Luján Feliu-Pascual, Alejandro Spicer, Charlotte Ricketts, Sally Hitti, Rebekkah Forman, Oliver Hersheson, Joshua Houlden, Henry PeerJ Genetics BACKGROUND: Charcot-Marie-Tooth (CMT) disease is the most common neuromuscular disorder in humans affecting 40 out of 100,000 individuals. In 2008, we described the clinical, electrophysiological and pathological findings of a demyelinating motor and sensory neuropathy in Miniature Schnauzer dogs, with a suspected autosomal recessive mode of inheritance based on pedigree analysis. The discovery of additional cases has followed this work and led to a genome-wide association mapping approach to search for the underlying genetic cause of the disease. METHODS: For genome wide association screening, genomic DNA samples from affected and unaffected dogs were genotyped using the Illumina CanineHD SNP genotyping array. SBF2 and its variant were sequenced using primers and PCRs. RNA was extracted from muscle of an unaffected and an affected dog and RT-PCR performed. Immunohistochemistry for myelin basic protein was performed on peripheral nerve section specimens. RESULTS: The genome-wide association study gave an indicative signal on canine chromosome 21. Although the signal was not of genome-wide significance due to the small number of cases, the SBF2 (also known as MTMR13) gene within the region of shared case homozygosity was a strong positional candidate, as 22 genetic variants in the gene have been associated with demyelinating forms of Charcot-Marie-Tooth disease in humans. Sequencing of SBF2 in cases revealed a splice donor site genetic variant, resulting in cryptic splicing and predicted early termination of the protein based on RNA sequencing results. CONCLUSIONS: This study reports the first genetic variant in Miniature Schnauzer dogs responsible for the occurrence of a demyelinating peripheral neuropathy with abnormally folded myelin. This discovery establishes a genotype/phenotype correlation in affected Miniature Schnauzers that can be used for the diagnosis of these dogs. It further supports the dog as a natural model of a human disease; in this instance, Charcot-Marie-Tooth disease. It opens avenues to search the biological mechanisms responsible for the disease and to test new therapies in a non-rodent large animal model. In particular, recent gene editing methods that led to the restoration of dystrophin expression in a canine model of muscular dystrophy could be applied to other canine models such as this before translation to humans. PeerJ Inc. 2019-11-21 /pmc/articles/PMC6875392/ /pubmed/31772832 http://dx.doi.org/10.7717/peerj.7983 Text en ©2019 Granger et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Genetics Granger, Nicolas Luján Feliu-Pascual, Alejandro Spicer, Charlotte Ricketts, Sally Hitti, Rebekkah Forman, Oliver Hersheson, Joshua Houlden, Henry Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model |
title | Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model |
title_full | Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model |
title_fullStr | Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model |
title_full_unstemmed | Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model |
title_short | Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing SBF2 (MTMR13) genetic variant: a new spontaneous clinical model |
title_sort | charcot-marie-tooth type 4b2 demyelinating neuropathy in miniature schnauzer dogs caused by a novel splicing sbf2 (mtmr13) genetic variant: a new spontaneous clinical model |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875392/ https://www.ncbi.nlm.nih.gov/pubmed/31772832 http://dx.doi.org/10.7717/peerj.7983 |
work_keys_str_mv | AT grangernicolas charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel AT lujanfeliupascualalejandro charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel AT spicercharlotte charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel AT rickettssally charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel AT hittirebekkah charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel AT formanoliver charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel AT hershesonjoshua charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel AT houldenhenry charcotmarietoothtype4b2demyelinatingneuropathyinminiatureschnauzerdogscausedbyanovelsplicingsbf2mtmr13geneticvariantanewspontaneousclinicalmodel |